Atlas Trials

NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis

Clinical trial NCT05734599 · UNKNOWN

Trial details

NCT number
NCT05734599
Sponsor
Huazhong University of Science and Technology
Status
UNKNOWN
Study type
OBSERVATIONAL
Metabolic Dysfunction-associated Fatty Liver DiseaseMetabolic Disease
Start date
2023-03-01
Primary completion
2023-12-31
Enrollment
1194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.